Options for managing tolerance include a brief dose reduction for 4 to 8 weeks ("drug holiday" at a lower dose, not complete cessation), lifestyle optimization to maximize the medication effect, evaluation for other contributing factors (thyroid function, cortisol, sleep quality, medication interactions), and consideration of adding a complementary compound to address specific aspects of the plateau
Why choose us in Kochi for skin treatment
Some clinicians also combine a low dose of GHRP-2 (50-75 mcg) with a GHRH analog such as CJC-1295 (without DAC) to achieve a synergistic GH release, then switch to Ipamorelin once GH levels normalize
Sermorelin operates as a synthetic growth hormone-releasing hormone (GHRH) analogue, mimicking the natural hormone produced by the hypothalamus
Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT)
P.PontelliM